PAVmed (PAVM) EPS (Diluted) (QoQ) (2016 - 2025)
PAVmed (PAVM) EPS (Diluted) (QoQ) (2016 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | PAVmed | 10.85 Mn | 9.31 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68.54% |
| Sep 30, 2025 | 60.10% |
| Jun 30, 2025 | -318.31% |
| Mar 31, 2025 | 1,535.06% |
| Jun 30, 2024 | 54.53% |
| Mar 31, 2024 | -19.16% |
| Dec 31, 2023 | 7.51% |
| Sep 30, 2023 | -13.22% |
| Jun 30, 2023 | 24.49% |
| Mar 31, 2023 | 19.55% |
| Dec 31, 2022 | 21.02% |
| Sep 30, 2022 | 0.84% |
| Jun 30, 2022 | 77.46% |
| Mar 31, 2022 | 2.00% |
| Dec 31, 2021 | -40.60% |
| Sep 30, 2021 | -6.49% |
| Jun 30, 2021 | -21.45% |
| Mar 31, 2021 | -7.88% |
| Dec 31, 2020 | -58.57% |
| Sep 30, 2020 | 1.63% |